175 related articles for article (PubMed ID: 21990607)
1. Unique FISH patterns associated with cancer progression of oral dysplasia.
Poh CF; Zhu Y; Chen E; Berean KW; Wu L; Zhang L; Rosin MP
J Dent Res; 2012 Jan; 91(1):52-7. PubMed ID: 21990607
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer.
Taoudi Benchekroun M; Saintigny P; Thomas SM; El-Naggar AK; Papadimitrakopoulou V; Ren H; Lang W; Fan YH; Huang J; Feng L; Lee JJ; Kim ES; Hong WK; Johnson FM; Grandis JR; Mao L
Cancer Prev Res (Phila); 2010 Jul; 3(7):800-9. PubMed ID: 20570883
[TBL] [Abstract][Full Text] [Related]
3. Gain of hTERC: a genetic marker of malignancy in oral potentially malignant lesions.
Dorji T; Monti V; Fellegara G; Gabba S; Grazioli V; Repetti E; Marcialis C; Peluso S; Di Ruzza D; Neri F; Foschini MP
Hum Pathol; 2015 Sep; 46(9):1275-81. PubMed ID: 26170010
[TBL] [Abstract][Full Text] [Related]
4. Multiple aberrations of chromosome 3p detected in oral premalignant lesions.
Tsui IF; Rosin MP; Zhang L; Ng RT; Lam WL
Cancer Prev Res (Phila); 2008 Nov; 1(6):424-9. PubMed ID: 19138989
[TBL] [Abstract][Full Text] [Related]
5. Recurrent copy number alterations involving EGFR, CDKN2A, and CCND1 in oral premalignant lesions.
Jäwert F; Fehr A; Öhman J; Stenman G; Kjeller G
J Oral Pathol Med; 2022 Jul; 51(6):546-552. PubMed ID: 35488777
[TBL] [Abstract][Full Text] [Related]
6. Fluorescence in situ hybridization for detecting genomic alterations of cyclin D1 and p16 in oral squamous cell carcinomas.
Uzawa N; Sonoda I; Myo K; Takahashi K; Miyamoto R; Amagasa T
Cancer; 2007 Nov; 110(10):2230-9. PubMed ID: 17893905
[TBL] [Abstract][Full Text] [Related]
7. Progress risk assessment of oral premalignant lesions with saliva miRNA analysis.
Yang Y; Li YX; Yang X; Jiang L; Zhou ZJ; Zhu YQ
BMC Cancer; 2013 Mar; 13():129. PubMed ID: 23510112
[TBL] [Abstract][Full Text] [Related]
8. Multiple pathways in the FGF signaling network are frequently deregulated by gene amplification in oral dysplasias.
Tsui IF; Poh CF; Garnis C; Rosin MP; Zhang L; Lam WL
Int J Cancer; 2009 Nov; 125(9):2219-28. PubMed ID: 19623652
[TBL] [Abstract][Full Text] [Related]
9. DNA ploidy analysis by image cytometry helps to identify oral epithelial dysplasias with a high risk of malignant progression.
Torres-Rendon A; Stewart R; Craig GT; Wells M; Speight PM
Oral Oncol; 2009 Jun; 45(6):468-73. PubMed ID: 18805043
[TBL] [Abstract][Full Text] [Related]
10. Methylation of p16 CpG island associated with malignant progression of oral epithelial dysplasia: a prospective cohort study.
Cao J; Zhou J; Gao Y; Gu L; Meng H; Liu H; Deng D
Clin Cancer Res; 2009 Aug; 15(16):5178-83. PubMed ID: 19671846
[TBL] [Abstract][Full Text] [Related]
11. EGFR expression and copy number changes in low T-stage oral squamous cell carcinomas.
Rössle M; Weber CS; Züllig L; Graf N; Jochum W; Stöckli SJ; Moch H; Huber GF
Histopathology; 2013 Aug; 63(2):271-8. PubMed ID: 23763474
[TBL] [Abstract][Full Text] [Related]
12. Genetic Abnormalities in Oral Leukoplakia and Oral Cancer Progression.
Kil TJ; Kim HS; Kim HJ; Nam W; Cha IH
Asian Pac J Cancer Prev; 2016; 17(6):3001-6. PubMed ID: 27356725
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of matrix metalloproteinase-1 and -9 mRNA is associated with progression of oral dysplasia to cancer.
Jordan RC; Macabeo-Ong M; Shiboski CH; Dekker N; Ginzinger DG; Wong DT; Schmidt BL
Clin Cancer Res; 2004 Oct; 10(19):6460-5. PubMed ID: 15475433
[TBL] [Abstract][Full Text] [Related]
14. Phospholipase C-γ1 expression correlated with cancer progression of potentially malignant oral lesions.
Ma LW; Zhou ZT; He QB; Jiang WW
J Oral Pathol Med; 2013 Jan; 42(1):47-52. PubMed ID: 22671975
[TBL] [Abstract][Full Text] [Related]
15. Potential marker of oral squamous cell carcinoma aggressiveness detected by fluorescence in situ hybridization in fine-needle aspiration biopsies.
Miyamoto R; Uzawa N; Nagaoka S; Nakakuki K; Hirata Y; Amagasa T
Cancer; 2002 Nov; 95(10):2152-9. PubMed ID: 12412169
[TBL] [Abstract][Full Text] [Related]
16. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity and immunoexpression of PTEN in oral epithelial dysplasia and squamous cell carcinoma.
Chaves FN; Bezerra TMM; Moraes DC; Costa SFDS; Silva PGB; Alves APNN; Costa FWG; Bernardes VF; Pereira KMA
Exp Mol Pathol; 2020 Feb; 112():104341. PubMed ID: 31730755
[TBL] [Abstract][Full Text] [Related]
18. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Girod SC; Pfeiffer P; Ries J; Pape HD
Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
[TBL] [Abstract][Full Text] [Related]
19. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England.
Warnakulasuriya S; Kovacevic T; Madden P; Coupland VH; Sperandio M; Odell E; Møller H
J Oral Pathol Med; 2011 Oct; 40(9):677-83. PubMed ID: 21762430
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity (LOH) profiles--validated risk predictors for progression to oral cancer.
Zhang L; Poh CF; Williams M; Laronde DM; Berean K; Gardner PJ; Jiang H; Wu L; Lee JJ; Rosin MP
Cancer Prev Res (Phila); 2012 Sep; 5(9):1081-9. PubMed ID: 22911111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
